Critical piece is from 9mins to 11 mins when it details that if they are in only  12 clinics with 9 docs per clinic doing 35 prescriptions then the revenue is $150 M per year. Bear in mind that the market research they have done suggest that 1/3 of ALL doctors would prescribe this to 100% of their female patience’s

There are 7.5 m women with endo and 27m with chronic pelvic pain. They are the only test to diagnose this. They are also at advance stage to developing a treatment. To put this is perspective ABVIE paid 575m for a phase 2 trial a few years back. Bhare and Phizer are also in the space.

The numbers above only relate to the US.

Finically secure, going to Nasdaq

Listen to the whole thing, its quite incredible

 

http://wsw.com/webcast/ldmicro14/pred/index.aspx